CFO Moves this week include:
|Axiom||ConocoPhillips||Organon & Co.|
|Scientific Games Corporation||Exela Technologies, Inc.||AgeX Therapeutics , Inc.|
|Republic Services, Inc.||AdaptHealth Corp.||Ulrich Barn Builders|
|Seer, Inc.||Ascent Resources, LLC||FabFitFun|
|Vx Capital Partners||3D Systems||Asklepios BioPharmaceutical, Inc.|
|Avidity Biosciences||Science 37||Toast Distillers, Inc.|
|Advisor Group||Amerant Bancorp Inc.||Electromed, Inc.|
|The Muncy Bank and Trust Company||American Kennel Club||Self Financial|
|Akcea Therapeutics, Inc.||Cadiz Inc.||OODA Health|
Would you like to receive our weekly CFO Moves directly in your email? Click the SIGN ME UP! button on the right of the blog page.
Should you have any CFO Moves to report, please email us.
NOTE: CFO Search Report available monthly to CFOs only. Read more here.
CFO Moves is published by Samuel Dergel (Executive Search Consultant and CFO & Financial Executive Search Specialist with Dergel Executive Search). Samuel can be reached by email at firstname.lastname@example.org or by phone at +1 (415) 738-2070.
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Axiom [NEW YORK] announced it has named Sloane Googin its next CFO. Since 2018, Googin has served as the CFO for Dynata. Prior to Dynata, Googin spent 10 years at The Nielsen Company, where he last served as SVP of Global Financial Planning and Analysis. He also served as CFO to various Nielsen business units, including the Global Business Services Division. Prior to his time at Nielsen, he held various executive finance positions at General Electric Company and General Electric Capital.
ConocoPhillips [HOUSTON] (NYSE: COP) announced the retirement of Don E. Wallette, Jr. as executive vice president and chief financial officer, effective on Aug. 31, 2020. In conjunction with Wallette’s retirement, the company also announced that William (Bill) L. Bullock, Jr., currently president, Asia Pacific Middle East, will assume the role of executive vice president and chief financial officer on Sept. 1, 2020.
Organon & Co. [KENILWORTH, NJ], the intended spinoff of its women’s health, legacy brands and biosimilars businesses of Merck (NYSE: MRK), announced the appointment of Matthew Walsh as Chief Financial Officer. Walsh will join Organon from Allergan where he served as Executive Vice President (EVP) and Chief Financial Officer (CFO). Prior to Allergan, he served as CFO at Catalent. The spinoff transaction is planned for the first half of 2021.
Scientific Games Corporation [LAS VEGAS] (NASDAQ: SGMS) announced that Michael Eklund will become its Chief Financial Officer on June 1, 2020. Eklund spent more than 20 years at Dell Technologies in both financial and operational roles. Most recently, he has served as CFO of IRI. Michael Quartieri will remain full time with the Company until June 30, 2020 and will serve in a consulting role through December 31, 2020.
Exela Technologies, Inc. [IRVING, TX] (NASDAQ: XELA) announced that Shrikant Sortur, who has served as Exela’s Executive Vice President, Global Finance since 2017, has been promoted to Chief Financial Officer as part of the Company’s succession planning process. Jim Reynolds, who has served as CFO since 2017, will remain a non-employee member of the Company’s Board of Directors. Sortur previously served as Senior Vice President, Global Finance of SourceHOV Holdings, Inc. from 2016 until SourceHOV’s business combination with Novitex Holdings, Inc. in July 2017. Sortur served in positions of increasing responsibility at predecessor companies to SourceHOV from 2002 until July 2017.
AgeX Therapeutics, Inc. [ALAMEDA, CA] (NYSE American: AGE) announced that Andrea Park has been appointed Chief Financial Officer. Park replaces Russell Skibsted who served in that role since the Company was organized in 2017. Park served as our Vice President of Finance and Controller since October 2019. Before joining AgeX, she served as Vice President of Finance and Controller of Lineage Cell Therapeutics, Inc.
Republic Services, Inc. [PHOENIX] (NYSE: RSG) announced that Charles F. “Chuck” Serianni, executive vice president and chief financial officer, has provided the Company one-year notice of his intent to retire, effective June 1, 2021. Serianni will be succeeded on June 1, 2020 by current executive vice president and chief transformation officer, Brian DelGhiaccio. Serianni will stay on as a special advisor to the CEO until his retirement in 2021 and will also work closely with DelGhiaccio to ensure a seamless transition. DelGhiaccio joined Republic Services in 1998 and has since held roles of increasing responsibility across the finance organization, including accounting, financial planning & analysis, investor relations, treasury and risk management. Prior to joining Republic, Mr. DelGhiaccio worked at Arthur Andersen as a senior consultant.
AdaptHealth Corp. [PLYMOUTH MEETING, PA] (NASDAQ: AHCO) announced the appointment of Jason A. Clemens as Chief Financial Officer, effective August 3, 2020. Clemens will succeed Gregg Holst. Clemens joins AdaptHealth from MEDNAX, Inc. where he currently serves as Senior Vice President and Operations Chief Financial Officer. Prior to joining MEDNAX, Clemens gained experience with the United States Army, supporting the Republic of Korea Army in Wonju, South Korea. He later served in progressive roles within operations management and finance at Accenture, Lennar, and Ryder.
Seer, Inc. [REDWOOD CITY, CA] announced the appointment of David R. Horn as Chief Financial Officer. Prior to joining Seer, Horn worked at Morgan Stanley for over 20 years, where he served as a Managing Director in the firm’s Global Healthcare Group within the Investment Banking Department. Horn was responsible for Morgan Stanley’s global Life Science Tools and Diagnostics practice and oversaw the Western Region Healthcare practice. In addition, Horn previously spent time working in the medical device and life science sectors where he served as Vice President of Business Development at RITA Medical Systems and, prior to that, in the same role at Chemdex Corporation.
Ascent Resources, LLC [OKLAHOMA CITY] announced that Brooks M. Shughart has been named Executive Vice President — Chief Financial Officer. Shughart will replace Jennifer M. Grigsby, who is leaving Ascent to pursue other interests. Shughart joins Ascent from First Reserve, where he worked for eight years, serving in various roles including his most recent position as Managing Director. Prior to First Reserve, Shughart worked in the Mergers and Acquisitions Group for Credit Suisse. Prior to Credit Suisse, he held positions in the energy groups of Lazard Freres and Donaldson, Lufkin & Jenrette / CS First Boston.
FabFitFun [LOS ANGELES] announced that J. Scott Di Valerio has joined the company as the first Chief Financial Officer. Di Valerio most recently served as Chief Operating and Financial Officer for Spiceworks. Prior to that, he was Chief Financial Officer for RetailMeNot and Chief Executive Officer for Outerwall. Earlier in his career, Di Valerio held various leadership roles at Lenovo Group, Microsoft Corporation, The Walt Disney Company and Mindwave Software, Inc.
Vx Capital Partners [SAN FRANCISCO] hired Sean Sullivan as Chief Financial Officer. Sullivan was previously Head of Americas at AerCap.Sullivan previously held senior positions at International Lease Finance Corporation, Allco Finance Group and Bank of America Leasing and Capital.
3D Systems [ROCK HILL, SC] (NYSE: DDD) announced that Wayne Pensky, former chief financial officer of Hexcel Corporation has been appointed interim CFO, replacing Todd Booth who has resigned from the company to pursue other opportunities. Pensky retired in 2017 after 24 years with Hexcel. Prior to that, he held a variety of financial leadership roles including head of Finance, Corporate Controller and Chief Accounting Officer. Pensky began his career with Arthur Andersen & Co, where he served 14 years.
Asklepios BioPharmaceutical, Inc. (AskBio) [RESEARCH TRIANGLE PARK, NC] announced the appointment of Tim Trost as Chief Financial Officer. Prior to joining AskBio, Trost most recently served as CFO at Chimerix. Previous to Chimerix, he was CFO at Argos Therapeutics. Prior to that, he was CFO at InteCardia. Previous to InteCardia, Mr. Trost served as CFO of Coastal Physician Group, after having joined the company as Vice President of Corporate Development. His earlier career included positions as Vice President of Finance at Morganite North America and Senior Manager at PwC.
Avidity Biosciences [SAN DIEGO] announced the appointment of Michael MacLean as Chief Financial Officer. Most recently, MacLean served as Chief Financial Officer of Akcea Therapeutics, Inc. Prior to Akcea, MacLean served as Chief Financial Officer of PureTech Health, plc, as well as Chief Accounting Officer of Biogen Inc.
Science 37 [LOS ANGELES] announced that Mike Zaranek has joined the company as its chief financial officer (CFO). Zaranek joins Science 37 from IQVIA’s Contract Sales and Medical Solutions, where he served as vice president of finance for the global business unit. Previously, Zaranek spent almost two decades in corporate development roles.
Toast Distillers, Inc. [MIAMI] announced that David Garretson was appointed CFO of the company. Prior to joining Toast Distillers, Inc., Garretson served as CFO for Invest Hospitality, an investment group based out of Houston, Texas, with ownership of U.S. Joël Robuchon hospitality assets. Before his tenure at Invest Hospitality, he was employed as senior vice president of finance for The ONE Group Hospitality, parent company of the world-renowned STK Steakhouse.
Amerant Bancorp Inc. [CORAL GABLES, FL] (NASDAQ: AMTB and AMTBB) announced that Carlos Iafigliola has been named Executive Vice President and Chief Financial Officer (CFO). Iafigliola has served as interim CFO since March 16, 2020 and has been with Amerant since 2004. Prior to being appointed interim CFO, Iafigliola served in various management positions, including Senior Vice President and Treasury Manager since 2015.
Electromed, Inc. [NEW PRAGUE, MN] (NYSE American: ELMD) announced that it has appointed Michael J. MacCourt as the Company’s Chief Financial Officer. Prior to his most recent role as Senior Director of Commercial Finance at Starkey Hearing Technologies, MacCourt spent over nine years at Medtronic in roles of increasing responsibility; concluding as Divisional CFO of the Lung Health business for the last five years. MacCourt also has consulting experience primarily at PricewaterhouseCoopers. MacCourt started his career at Procter & Gamble and then ConAgra Foods, where he held Financial Analyst, Cost Analyst and Business Analyst positions.
The Muncy Bank and Trust Company [MUNCY, PA] (OTC: MYBF) announced that Joseph K. O’Neill, Jr. has joined the company as Senior Vice President/Chief Financial Officer. Prior to joining Muncy Bank, O’Neill was a Senior Manager at Baker Tilly Virchow Krause, LLP.
American Kennel Club [NEW YORK] appointed Theodore (Ted) E. Phillips as Chief Financial Officer. Phillips was the former Director of Finance of United Church Funds and prior to that served as Director of Finance of Carnegie Hall for nine years, and as Vice President and Controller of the Merrill Lynch Corporate and Family Foundations.
Self Financial [Austin, TX] announced the appointment of Adam Chibib as Chief Financial Officer. Chibib previously served as a member on Self’s board for five years. Prior to joining Self, Chibib was a Partner at Silverton Partners. In his most recent operating role, he was President and CFO of Multimedia Games. Chibib also served as founder and CFO of BroadJump (acquired by Motive), CFO of Waveset (acquired by Sun Microsystems), CFO of TippingPoint Technologies (acquired by 3Com), and as CFO of NetSpend.
Akcea Therapeutics, Inc. [BOSTON] (NASDAQ: AKCA) announced that Michael D. Price has joined the company as executive vice president and chief financial officer. Before joining Akcea, Price served as executive vice president and chief financial officer and was elected to the company’s board of directors of Novelion Therapeutics. Before that, Price served as vice president and chief financial officer at Noven Pharmaceuticals, Inc., from 2007 to 2016. Prior to Noven, he was at Bentley Pharmaceuticals, Inc. from 1992 to 2006, serving as vice president, chief financial officer, treasurer and secretary. He also was a member of Bentley’s board of directors for nine years.
Cadiz Inc. [LOS ANGELES] (NASDAQ: CDZI) announced that current CFO Timothy Shaheen, has become Director of Development. Stan Speer, who has been a financial consultant to the Company for five years, will take over as Chief Financial Officer. Speer brings decades of financial management experience to this position, including previous tenure as Cadiz CFO from 1997-2003, and roles as a Managing Director with global professional services firm Alvarez & Marsal, and as a partner with Coopers & Lybrand (now PricewaterhouseCoopers), where he spent 14 years.
OODA Health [SAN FRANCISCO] announced that Brian Meewes is joining the company in the role of Chief Financial Officer and Chief Operating Officer. Meewes joins OODA Health from Alto Pharmacy. Prior to Alto, Brian was VP and Head of Finance at Symphony Commerce, and previously was head of strategic finance and analytics at BigCommerce. Brian previously spent seven years at Amazon as finance leader for their fulfillment center and worldwide supply chain analytics, as well as several of their growth business lines, including Amazon Fresh and Amazon.com grocery.
CORAVIN, Inc. [BEDFORD, MA] announced the appointment of Jeff Lasher as the company’s Chief Financial Officer. Lasher joins Coravin with significant prior public company CFO experience at Crocs, Inc. and West Marine Inc., as well as the privately held International Car Wash Group. His professional career experience began at Ford Motor Company.